Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Canadian authorities assessing reimbursement for newly approved cystic fibrosis treatment Kalydeco

Dec. 4, 2012

Health Canada approves Cymbalta for pain associated with osteoarthritis of the knee

Nov. 13, 2012

Health Canada approves Seebri Breezhaler for COPD

Oct. 23, 2012

Health Canada approves new drug submission for Cinryze

Oct. 23, 2012

New safety information for Zofran issued in Canada

Oct. 10, 2012

Apricus Biosciences plans Canadian submission for MycoVa

Oct. 2, 2012

Health Canada approves Dermagraft for diabetic foot ulcers

Sep. 7, 2012

Health Canada approves Treanda

Aug. 29, 2012

Tarceva approved in Canada for specific NSCLC subtype

Aug. 14, 2012

Xiaflex approved in Canada

July 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...